Periodic Reporting for period 1 - ImmuNovation (Modular Targeted Nanoplatform for Immune Cell Regulation and Therapy)

Cancer is a major cause of disability and mortality worldwide. Despite the promising clinical results of immunotherapies, they suffer from multiple limitations, including manufacturing challenges, limited efficacy, toxicity, and high costs. Recent data highlight the promising...